Leerink Partners started coverage on shares of PureTech Health (NASDAQ:PRTC – Free Report) in a research note published on Monday, MarketBeat reports. The brokerage issued an outperform rating and a $45.00 price target on the stock.
PureTech Health Stock Up 0.5 %
PRTC opened at $19.89 on Monday. PureTech Health has a fifty-two week low of $17.08 and a fifty-two week high of $34.00. The company has a fifty day moving average of $22.26 and a two-hundred day moving average of $25.68.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in PureTech Health stock. Birch Hill Investment Advisors LLC acquired a new stake in PureTech Health plc (NASDAQ:PRTC – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 302,000 shares of the company’s stock, valued at approximately $7,550,000. Birch Hill Investment Advisors LLC owned approximately 1.26% of PureTech Health as of its most recent filing with the Securities and Exchange Commission (SEC). 0.04% of the stock is owned by institutional investors and hedge funds.
PureTech Health Company Profile
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- Breakout Stocks: What They Are and How to Identify Them
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- Insider Buying Explained: What Investors Need to Know
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- 3 Healthcare Dividend Stocks to Buy
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.